Profile for AIM ImmunoTech Inc. (AIM)

$ 2.80   0.30 (+12.00%) Volume: 10.82m 8:00 PM EDT May 29, 2020
After Hours:  $ 2.83   0.03 (+1.07%) Volume: 130.54k 7:59 PM EDT May 29, 2020
Business Description:
Hemispherx Biopharma Inc is a specialty pharmaceutical company. It is primarily engaged in the clinical development of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune-based disorders.
Address: 2117 SW Highway 484, Ocala, FL, USA, 34473
Telephone: +1 352 448-7797 Website: https://www.aimimmuno.com
Facsimile: +1 352 480-4620 Email: [email protected]
Details
CEO: Thomas K. Equels
Employees: 26 Market Cap: 81.72m
Issue Type: CS
Auditor: Morrison, Brown, Argiz & Farra, LLC
Last Audit: Unqualified Opinion
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 946644
Industry: Biotechnology
Sub-Industry:    Biotechnology
NAICS: Biological Product (except Diagnostic) Manufacturing (325414)
SIC: Biological Products, Except Diagnostic Substances (2836)